Differences in management of atrial fibrillation between cardiologists and non-cardiologists in Greece

Vassilios P Vassilikos1, Aggeliki Mantziari, Christos A Goudis

  • 1First Cardiology Department, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Insights

Greek physicians show differing atrial fibrillation (AF) management strategies. Non-cardiologists frequently use digitalis and are hesitant with anticoagulants in elderly patients, unlike cardiologists.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Atrial fibrillation (AF) management varies across healthcare settings.
  • Understanding treatment disparities is crucial for improving patient outcomes.

Purpose of the Study:

  • To analyze trends in atrial fibrillation (AF) management in Greece.
  • To compare treatment practices between cardiologists and non-cardiologists.

Main Methods:

  • A survey of 500 physicians (cardiologists, internists, general practitioners) in Greece.
  • Questionnaires assessed management of paroxysmal, persistent, and permanent AF.
  • Data collected from 309 respondents (194 cardiologists, 115 non-cardiologists).

Main Results:

  • Non-cardiologists tend to cardiovert paroxysmal AF in emergency departments.
  • Cardiologists favor propafenone/ibutilide, while non-cardiologists use digitalis more for cardioversion.
  • Differences observed in post-cardioversion antiarrhythmic drug use, rate control preferences (beta-blockers vs. digitalis), and antiplatelet/anticoagulant choices.

Conclusions:

  • Significant discrepancies exist in AF management between Greek cardiologists and non-cardiologists.
  • Non-cardiologists over-rely on digitalis and underuse beta-blockers.
  • Non-cardiologists prefer clopidogrel over aspirin and are less likely to prescribe anticoagulants in elderly patients.
Abstract

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...